查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611182

美国动物保健市场规模、份额和趋势分析报告：按动物类型、产品、疫苗类型、疾病、给药途径、分销管道和细分市场进行预测（2025-2030）

U.S. Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production Animal, Companion Animal), By Product, By Type Of Vaccine, By Disease, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

美国动物保健市场的成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，美国动物保健市场规模预计将达到197.7亿美元，2025年至2030年复合年增长率为7.97%。

这个市场主要是由动物数量和饲养率的增加、动物支出的增加、对预防性动物保健的日益关注、动物用药品学的进步以及由于研发投资增加而推出的创新产品所推动的。例如，2024年11月，Bimeda推出了MoxiSolv注射液（莫昔克丁），这是一种FDA批准的用于肉牛和非泌乳牛的寄生虫杀虫剂，装在方便、防溅的500mL塑胶瓶中。

此外，通用感染疾病的增加、牲畜数量的增加、对预防性医疗保健的兴趣增加以及牲畜支出的增加也推动了该行业。美国畜牧业人口不断增加，用于肉类生产的牛、羊、猪和家禽数量大幅增加。例如，根据世界市场与贸易报告、美国对外农业服务局畜禽报告显示，截至2024年1月，美国牛隻存栏量为8,780万头，猪隻存栏量为7,497万头。这些大量的牲畜需要全面的兽医护理和医疗干预，以保持它们的健康和生产力。

此外，畜牧业每年带来超过 700 亿美元的经济重要性，促使相关人员优先考虑健康管理，以减少疾病造成的潜在损失。消费者对优质牛肉和乳製品的需求不断增加，以及对永续农业实践的认识不断提高，也在牛健康管理解决方案的采用中发挥关键作用。政府支持的措施和加强农村地区兽医服务正在进一步加强该部门并确保其持续扩张。

此外，药物饲料添加剂的核准增加也透过改善牲畜健康和生产效率来显着推动市场。例如，2024年6月，FDA核准Elanco的减少甲烷排放的饲料添加剂Bovaer（3-NOP）用于泌乳牛。 Bovaer 每头牛可减少 30% 的甲烷排放，这意味着如果 100 万牛使用，每年可减少的排放相当于减少 285,000 辆汽车的排放量。这项创新透过碳市场为酪农提供经济奖励，支持永续努力并实现全球气候目标。 Elanco 将与帝斯曼芬美意合作，在整个北美地区分销 Bovaer，为永续农业实践和乳製品产业的竞争力做出贡献。

同样，动物用药品的快速发展也为该行业创造了利润丰厚的机会。动物用药品的开发导致了针对多种动物疾病和疾病的更强化和更有效的治疗方法的开发。此外，对创新动物用药品的需求是由新药物和治疗方法可以为动物带来更好的结果，减少副作用并提高疗效。例如，2024年9月，默克动物保健公司推出NOBIVAC NXT FeLV，这是第一个针对猫白血病病毒（FeLV）的RNA疫苗，扩大了其NOBIVAC NXT疫苗平台。这种创新疫苗针对 FeLV（一种常见的猫科动物感染疾病）提供了最佳保护，并将在全国兽医诊所提供。同样，2024 年 6 月，Bimeda 推出了氟米松 Bimasone，这是 FDA核准的第一个用于治疗马、狗和猫发炎和过敏性疾病的学名药。

美国动物保健市场报告亮点

  • 依产品划分，2024年医药领域的销售份额最高。然而，生技药品领域预计在预测期内将以最快的复合年增长率成长。
  • 按动物划分，由于通用感染疾病的增加、牲畜数量的增加、对预防医学的兴趣增加以及动物支出的增加，到 2024 年，生产动物部分将占最大份额。
  • 按疫苗类型划分，牛疫苗预计将在 2024 年占据市场主导地位，并在预测期内以 9.52% 的复合年增长率实现最快增长。
  • 从给药途径来看，2024 年口服药物在市占率中占据主导地位。这一增长归因于产业参与者推出咀嚼片等新产品。然而，局部给药领域预计在预测期内成长最快，复合年增长率为 9.13%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国动物保健市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国动物保健市场分析工具
    • 波特的分析
    • PESTEL分析
  • COVID-19 分析
  • 主要国家的宠物估计数量

第四章美国动物保健市场：动物类型的估计与趋势分析

  • 细分仪表板
  • 美国动物保健品市场波动分析
  • 美国动物保健市场规模与趋势分析：按动物类型（2018-2030）
    • 生产动物
    • 宠物

第五章美国动物保健市场：产品估算与趋势分析

  • 细分仪表板
  • 美国动物保健品市场波动分析
  • 美国动物保健市场规模与趋势分析：按产品（2018-2030）
    • 生物製药
    • 药品
    • 药物饲料添加剂

第六章美国动物保健市场：疫苗种类预估及趋势分析

  • 细分仪表板
  • 美国动物保健品市场波动分析
  • 美国动物保健市场规模与趋势分析：依疫苗类型（2018-2030）
    • 牛疫苗
    • 猪疫苗
    • 家禽疫苗
    • 水产养殖疫苗
    • 其他疫苗

第七章美国动物保健市场：疾病估计与趋势分析

  • 细分仪表板
  • 美国动物保健品市场波动分析
  • 美国动物保健市场规模及趋势分析：依疾病分类（2018-2030）
    • 牛疾病
    • 猪病
    • 家禽疾病
    • 水产养殖相关疾病
    • 其他疾病

第八章美国动物保健市场：给药途径预估及趋势分析

  • 细分仪表板
  • 美国动物保健品市场波动分析
  • 美国动物保健市场规模与趋势分析：依给药途径分类（2018-2030）
    • 口服
    • 注射
    • 局部的
    • 其他的

第九章美国动物保健市场：通路估算与趋势分析

  • 细分仪表板
  • 美国动物保健品市场波动分析
  • 美国动物保健市场规模及趋势分析：依通路划分（2018-2030）
    • 零售
    • 电子商务
    • 医院/诊所药房

第10章竞争格局

  • 市场参与企业分类
  • 企业市场分析/热图分析
  • 策略规划
    • 併购
    • 伙伴关係与协作
    • 其他的
  • 公司简介
    • Zoetis Inc.
    • Ceva Sante Animale
    • Merck &Co., Inc.
    • Vetoquinol SA
    • Boehringer Ingelheim Gmbh
    • Elanco Animal Health Incorporated
    • Virbac
    • Phibro Animal Health Corporation
    • Dechra Pharmaceuticals Plc
    • Bimeda, Inc.
    • Cargill, Incorporated.
    • Aurora Pharmaceutical, Inc.
    • Calier

第11章 要点

Product Code: GVR-4-68040-492-5

U.S. Animal Health Market Growth & Trends:

The U.S. animal health market size is expected to reach USD 19.77 billion by 2030, registering a CAGR of 7.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, an increasing focus on preventative animal healthcare, advances in veterinary medicine, and rising R&D investment in veterinary pharmaceuticals to launch innovative products. For instance, in November 2024, Bimeda launched MoxiSolv Injection (moxidectin), an FDA-approved parasiticide for beef and non-lactating dairy cattle, in a convenient, non-shattering 500 mL plastic bottle.

Furthermore, the industry is also driven by rising incidences of zoonotic diseases, increased livestock population, growing focus on preventive care, and growing animal expenditure. The livestock population in the U.S. has increased, with significant growth in cattle, sheep, pigs, and poultry being raised for meat production. For instance, as of January 2024, the U.S. had 87.8 million cattle and 74.97 million swine stock, according to the U.S. Foreign Agricultural Service's Livestock and Poultry: World Markets and Trade report. This substantial livestock population necessitates comprehensive veterinary care and medical interventions to maintain health and productivity.

In addition, the economic significance of the cattle industry, which contributes over USD 70 billion annually, has driven stakeholders to prioritize health management to mitigate potential losses due to diseases. The rising consumer demand for high-quality beef and dairy products and growing awareness of sustainable farming practices have also played a crucial role in adopting health management solutions for cattle. Government-backed initiatives and enhanced veterinary services in rural areas further strengthen the sector, ensuring its continued expansion.

Additionally, increasing approval of medicated feed additives significantly drives the market by improving livestock health and production efficiency. For instance, in June 2024, The FDA approved Elanco's methane-reducing feed additive, Bovaer (3-NOP), for lactating dairy cattle. Bovaer can reduce methane emissions by 30% per cow, potentially lowering emissions equivalent to removing 285,000 cars from the road annually if used by one million cows. This innovation offers financial incentives for dairy farmers through carbon markets, supporting sustainability efforts and meeting global climate goals. In partnership with dsm-Firmenich, Elanco will market Bovaer across North America, contributing to sustainable farming practices and enhancing the dairy industry's competitiveness.

Similarly, rapid advancements in veterinary medicine present lucrative opportunities in the industry. Improvements in animal pharmaceuticals result in the development of more focused and efficient therapies for many kinds of animal illnesses and ailments. Furthermore, the demand for innovative veterinary medications is being driven by new drugs and therapies that provide better results for animals, decreased side effects, and increased efficacy. For instance, in September 2024, Merck Animal Health expanded its NOBIVAC NXT vaccine platform by launching NOBIVAC NXT FeLV, the first RNA vaccine for feline leukemia virus (FeLV). This innovative vaccine offers optimized protection against FeLV, a common feline infectious disease, and is expected to be available at veterinary clinics nationwide. Similarly, in June 2024, Bimeda launched Bimasone, the first FDA-approved generic flumethasone, used to treat inflammation and allergic conditions in horses, dogs, and cats.

U.S. Animal Health Market Report Highlights:

  • Based on product, the pharmaceuticals segment accounted for the highest revenue share in 2024. However, the biologics segment is anticipated to grow at the fastest CAGR over the forecast period.
  • Based on animals, the production animal segment held the largest share in 2024 owing to rising incidences of zoonotic diseases, increased livestock population, growing focus on preventive care, and increased animal expenditure.
  • Based on the type of vaccine, the cattle vaccine segment dominated the market in 2024, and it is expected to grow fastest with a CAGR of 9.52% over the forecast period.
  • Based on the route of administration, the oral segment dominated the market with a share in 2024. This growth can be attributed to new product launches such as chewable tablets by the industry players. However, the topical segment is anticipated to grow at the fastest CAGR of 9.13% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis
    • 1.6.2. Global Market: CAGR Calculation
  • 1.7. Research Scope and Assumptions
    • 1.7.1. List of Secondary Sources
    • 1.7.2. List of Primary Sources
    • 1.7.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Animal Health Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising Prevalence of Animal Diseases
      • 3.2.1.2. Growing Uptake Of Pet Insurance
      • 3.2.1.3. Increase In Pet Population & Pet Humanization
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Adverse effects associated with therapies
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. U.S. Animal Health Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal landscape
  • 3.4. Covid-19 Analysis
  • 3.5. Estimated Pet Population by key countries

Chapter 4. U.S. Animal Health Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Animal Health Market Movement Analysis
  • 4.3. U.S. Animal Health Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
    • 4.3.1. Production Animals
      • 4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.2. Poultry
        • 4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.3. Swine
        • 4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.4. Cattles
        • 4.3.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.5. Sheep & Goats
        • 4.3.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.6. Fish
        • 4.3.1.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Companion Animals
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2. Dogs
        • 4.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.3. Cats
        • 4.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4. Horses
        • 4.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.5. Others
        • 4.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Animal Health Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Animal Health Market Movement Analysis
  • 5.3. U.S. Animal Health Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
    • 5.3.1. Biologics
      • 5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.2. Vaccines
        • 5.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.2. Attenuated Live Vaccines
          • 5.3.1.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.3. Inactivated Vaccines
          • 5.3.1.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.4. Subunit Vaccines
          • 5.3.1.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.5. DNA Vaccines
          • 5.3.1.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.2. Recombinant Vaccines
          • 5.3.1.2.5.3. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.4. Autogenous Vaccines
          • 5.3.1.2.5.5. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.6. Other Biologics
          • 5.3.1.2.5.7. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Pharmaceuticals
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.2. Parasiticides
        • 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.3. Anti-infectives
        • 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.4. Anti-inflammatory
        • 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.5. Analgesics
        • 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.6. Other Pharmaceuticals
        • 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Medicinal Feed Additives
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Animal Health Market: Type of Vaccine Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Animal Health Market Movement Analysis
  • 6.3. U.S. Animal Health Market Size & Trend Analysis, by Type of Vaccine, 2018 to 2030 (USD Million)
    • 6.3.1. Cattle Vaccine
      • 6.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Porcine Vaccine
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Poultry Vaccine
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Aquaculture Vaccine
      • 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Other Vaccines
      • 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Animal Health Market: Disease Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Animal Health Market Movement Analysis
  • 7.3. U.S. Animal Health Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
    • 7.3.1. Cattle Disease
      • 7.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Porcine Disease
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Poultry Disease
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Aquaculture Disease
      • 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Other Disease
      • 7.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Animal Health Market: Route of Administration Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Animal Health Market Movement Analysis
  • 8.3. U.S. Animal Health Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
    • 8.3.1. Oral
      • 8.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. Injectable
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.2. Subcutaneous
        • 8.3.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3. Intramuscular
        • 8.3.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.4. Intravenous
        • 8.3.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Topical
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Other
      • 8.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Animal Health Market: Distribution Channel Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. U.S. Animal Health Market Movement Analysis
  • 9.3. U.S. Animal Health Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
    • 9.3.1. Retail
      • 9.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. E-Commerce
      • 9.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Hospital/ Clinic Pharmacy
      • 9.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Position Analysis/ Heat Map Analysis
  • 10.3. Strategy Mapping
    • 10.3.1. Mergers & Acquisitions
    • 10.3.2. Partnerships & Collaborations
    • 10.3.3. Others
  • 10.4. Company Profiles
    • 10.4.1. Zoetis Inc.
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Ceva Sante Animale
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Merck & Co., Inc.
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Vetoquinol S.A.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. Boehringer Ingelheim Gmbh
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Elanco Animal Health Incorporated
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Virbac
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. Phibro Animal Health Corporation
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Dechra Pharmaceuticals Plc
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Bimeda, Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives
    • 10.4.11. Cargill, Incorporated.
      • 10.4.11.1. Participant's Overview
      • 10.4.11.2. Financial Performance
      • 10.4.11.3. Product Benchmarking
      • 10.4.11.4. Strategic Initiatives
    • 10.4.12. Aurora Pharmaceutical, Inc.
      • 10.4.12.1. Participant's Overview
      • 10.4.12.2. Financial Performance
      • 10.4.12.3. Product Benchmarking
      • 10.4.12.4. Strategic Initiatives
    • 10.4.13. Calier
      • 10.4.13.1. Participant's Overview
      • 10.4.13.2. Financial Performance
      • 10.4.13.3. Product Benchmarking
      • 10.4.13.4. Strategic Initiatives

Chapter 11. Key Takeaways

List of Tables

  • Table 1 Cost of surgeries, USD
  • Table 2 Pricing analysis for vaccines (USD), 2024
  • Table 3 Estimated animal population in U.S. by key species, 2018 to 2023
  • Table 4 U.S. Animal Health Market Revenue Estimates and Forecast, By Product, 2018 - 2030 (USD Million)
  • Table 5 U.S. Animal Health Market Revenue Estimates and Forecast, By Biologics, 2018 - 2030 (USD Million)
  • Table 6 U.S. Animal Health Market Revenue Estimates and Forecast, By Vaccines, 2018 - 2030 (USD Million)
  • Table 7 U.S. Animal Health Market Revenue Estimates and Forecast, By Pharmaceuticals, 2018 - 2030 (USD Million)
  • Table 8 U.S. Animal Health Market Revenue Estimates and Forecast, By Animal Type, 2018-2030 (USD million)
  • Table 9 U.S. Animal Health Market Revenue Estimates and Forecast, By Production Animal, 2018 - 2030 (USD Million)
  • Table 10 U.S. Animal Health Market Revenue Estimates and Forecast, By Companion Animal, 2018 - 2030 (USD Million)
  • Table 11 U.S. Animal Health Market Revenue Estimates and Forecast, By Type of Vaccine, 2018 - 2030 (USD Million)
  • Table 12 U.S. Animal Health Market Revenue Estimates and Forecast, By Disease, 2018 - 2030 (USD Million)
  • Table 13 U.S. animal health market estimates and forecast, by Route of administration, 2018 - 2030 (USD Million)
  • Table 14 U.S. Animal Health Market Revenue Estimates and Forecast, By Injectables, 2018 - 2030 (USD Million)
  • Table 15 U.S. Animal Health Market Revenue Estimates and Forecast, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Participants' overview
  • Table 17 Financial performance
  • Table 18 Products benchmarking
  • Table 19 Estimated Company Market Share in U.S Animal Health Market
  • Table 20 Estimated Company Market Share in U.S Animal Health Pharmaceutical Market
  • Table 21 Estimated Company Market Share in U.S Animal Health Vaccines Market
  • Table 22 Estimated Company Market Share in the U.S Animal Health Medicated Feed Additives Market
  • Table 23 Key market players initiating expansion
  • Table 24 Key market players initiating mergers & acquisitions
  • Table 25 Key market players initiating partnerships & collaborations.
  • Table 26 Key market players initiating service launches/expansions
  • Table 27 Key market players undertaking approvals
  • Table 28 Key market players undertaking other activities
  • Table 29 List of key market players

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 General methodology for Commodity flow analysis of Animal Health market
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Segment-level bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market analysis, 2024 (USD billion)
  • Fig. 17 Ancillary market outlook, 2024
  • Fig. 18 U.S. animal health market dynamics
  • Fig. 19 Estimated number of U.S. households owning a pet (2024)
  • Fig. 20 U.S. animal health market: PORTER's analysis
  • Fig. 21 U.S. animal health market: PESTEL analysis
  • Fig. 22 U.S. Animal Health market by product type: Key takeaways
  • Fig. 23 U.S. Animal Health market by product type market share, 2024 & 2030
  • Fig. 24 Biologics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Attenuated vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Inactivated vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Subunit vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 DNA vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Recombinant vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Autogenous vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Other biologics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pharmaceuticals market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Parasiticides market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Anti-infectives market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Anti-inflammatory market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Analgesics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Other market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Medicinal feed additives market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. animal health market by animal type: Key takeaways
  • Fig. 41 U.S. animal health market by animal type market share, 2023 & 2030
  • Fig. 42 Production animal market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Swine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Poultry market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Cattle market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Sheep & goats market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Fish market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Companion animal market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Dogs market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Cats market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Horses market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Other market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 U.S. animal health market by type of vaccine: Key takeaways
  • Fig. 54 U.S. animal health market by type of vaccine market share, 2024 & 2030
  • Fig. 55 Cattle vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Porcine vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Poultry vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Aquaculture vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Other vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 U.S. animal health market by Disease: Key takeaways
  • Fig. 61 U.S. animal health market by disease market share, 2024 & 2030
  • Fig. 62 Porcine disease market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Poultry diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Cattle diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Aquaculture diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Other diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 U.S. animal health market by Route of administration: Key takeaways
  • Fig. 68 U.S. animal health market by Route of administration, market share, 2024 & 2030
  • Fig. 69 Oral market, 2018 - 2030 (USD Million)
  • Fig. 70 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 71 Subcutaneous market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Intramuscular market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Intravenous market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Topical market, 2018 - 2030 (USD Million)
  • Fig. 75 Other market, 2018 - 2030 (USD Million)
  • Fig. 76 U.S. animal health market by distribution channel: Key takeaways
  • Fig. 77 U.S. Animal Health market by distribution channel market share, 2024 & 2030
  • Fig. 78 Retail market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 E-Commerce market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Hospital/Clinic Pharmacy market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Market participant categorization
  • Fig. 82 Heat map analysis
  • Fig. 83 Key strategies deployed by market players